Pamela Kassing, Moderator: Nothing to Disclose

Geraldine B. McGinty MD, Presenter: Nothing to Disclose

James Vincent Rawson MD, Presenter: Nothing to Disclose

Mark Otto Bernardy MD, Presenter: Nothing to Disclose

Robert K. Zeman MD, Presenter: Stockholder, General Electric Company

1) Understand the current process of how reimbursement for new procedures and technology is obtained from CPT code development, valuation and coverage. 2) Using Lung Cancer Screening as an example, the participants will become familiar with the specific processes for obtaining coverage for new screening programs in the public and private sectors and how a myriad of governmental agencies and other policymaking groups are involved in determining which new procedures are covered. 3) Understand how obtaining coverage will bring this new technology to the mainstream. 4) Interactive techniques will be used to engage the audience in the consideration of strategic partnerships between industry, clinical research, governmental agencies and third party payors.

http://www.acr.org/

Kassing, P, McGinty, G, Rawson, J, Bernardy, M, Zeman, R, From Research to Reimbursement: Lung Cancer Screening and Healthcare Payment Policy (In Conjunction with the American College of Radiology).  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14000570.html